Hepatitis C and the absence of genomic data in low-income countries: a barrier on the road to elimination?

Niebel, M., Singer, J. B., Nickbakhsh, S., Gifford, R. J. and Thomson, E. C. (2017) Hepatitis C and the absence of genomic data in low-income countries: a barrier on the road to elimination? Lancet Gastroenterology and Hepatology, 2(10), pp. 700-701. (doi:10.1016/S2468-1253(17)30257-1) (PMID:28895545)

[img]
Preview
Text
147505.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

713kB

Abstract

Following the development of highly effective direct acting antiviral (DAA) compounds for the treatment of the hepatitis C virus (HCV), WHO has set out plans for disease eradication by 2030. Many barriers must be surmounted before this can be achieved, including buy-in from governments and policy makers, reduced drug costs, and improved infrastructure for the pathway from diagnosis to treatment. A comprehensive set of guidelines was produced by WHO in 2014, updated in 2016, and they are due to be revised later this year.

Item Type:Articles (Letter)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Gifford, Dr Robert and Singer, Dr Joshua and Thomson, Dr Emma and Nickbakhsh, Dr Sema and Niebel, Mr Marc
Authors: Niebel, M., Singer, J. B., Nickbakhsh, S., Gifford, R. J., and Thomson, E. C.
College/School:College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Journal Name:Lancet Gastroenterology and Hepatology
Publisher:Elsevier
ISSN:2468-1253
ISSN (Online):2468-1253
Published Online:06 September 2017
Copyright Holders:Copyright © 2017 Elsevier
First Published:First published in Lancet Gastroenterology and Hepatology 2(10):700-701
Publisher Policy:Reproduced in accordance with the copyright policy of the publisher.

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
645101T-cell mediated evolution of hepatitis C virus during acute infectionEmma ThomsonWellcome Trust (WELLCOTR)102789/Z/13/ZMVLS III - CENTRE FOR VIRUS RESEARCH